175 related articles for article (PubMed ID: 8924190)
1. Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo.
Sprouse J; Clarke T; Reynolds L; Heym J; Rollema H
Neuropsychopharmacology; 1996 Apr; 14(4):225-31. PubMed ID: 8924190
[TBL] [Abstract][Full Text] [Related]
2. Comparison of desmethylsertraline with sertraline as a monoamine uptake inhibitor in vivo.
Fuller RW; Hemrick-Luecke SK; Littlefield ES; Audia JE
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jan; 19(1):135-49. PubMed ID: 7535937
[TBL] [Abstract][Full Text] [Related]
3. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
[TBL] [Abstract][Full Text] [Related]
4. Acute uptake inhibition increases extracellular serotonin in the rat forebrain.
Rutter JJ; Auerbach SB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1319-24. PubMed ID: 7685386
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; De Montigny C; Blier P
Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
[TBL] [Abstract][Full Text] [Related]
6. Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline.
Rossi DV; Burke TF; McCasland M; Hensler JG
J Neurochem; 2008 May; 105(4):1091-9. PubMed ID: 18182050
[TBL] [Abstract][Full Text] [Related]
7. Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo.
Rollema H; Clarke T; Sprouse JS; Schulz DW
J Neurochem; 1996 Nov; 67(5):2204-7. PubMed ID: 8863532
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
Di Mascio M; Di Giovanni G; Di Matteo V; Prisco S; Esposito E
Brain Res Bull; 1998 Aug; 46(6):547-54. PubMed ID: 9744293
[TBL] [Abstract][Full Text] [Related]
9. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake.
Koe BK
J Clin Psychiatry; 1990 Dec; 51 Suppl B():13-7. PubMed ID: 2175308
[TBL] [Abstract][Full Text] [Related]
10. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
Béïque JC; de Montigny C; Blier P; Debonnel G
Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration.
Auerbach SB; Lundberg JF; Hjorth S
Neuropharmacology; 1995 Jan; 34(1):89-96. PubMed ID: 7623967
[TBL] [Abstract][Full Text] [Related]
12. The degree of inhibition of dopaminergic neurons in the ventral tegmental area induced by selective serotonin reuptake inhibitors is a function of the density-power-spectrum of the interspike interval.
Di Mascio M; Esposito E
Neuroscience; 1997 Aug; 79(4):957-61. PubMed ID: 9219958
[TBL] [Abstract][Full Text] [Related]
13. Role of serotonin receptors in the effect of sertraline on feeding behaviour.
Grignaschi G; Samanin R
Psychopharmacology (Berl); 1993; 110(1-2):203-8. PubMed ID: 7870886
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.
Tao R; Ma Z; Auerbach SB
J Pharmacol Exp Ther; 2000 Aug; 294(2):571-9. PubMed ID: 10900234
[TBL] [Abstract][Full Text] [Related]
15. Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.
Sotty F; Folgering JH; Brennum LT; Hogg S; Mørk A; Hertel P; Cremers TI
Neuropharmacology; 2009 Jul; 57(1):18-24. PubMed ID: 19376075
[TBL] [Abstract][Full Text] [Related]
16. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.
Bandoh T; Hayashi M; Ino K; Takada S; Ushizawa D; Hoshi K
Eur Neuropsychopharmacol; 2004 Dec; 14(6):471-8. PubMed ID: 15589386
[TBL] [Abstract][Full Text] [Related]
17. The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing.
Arborelius L; Wallsten C; Ahlenius S; Svensson TH
Eur J Pharmacol; 1999 Oct; 382(2):133-8. PubMed ID: 10528148
[TBL] [Abstract][Full Text] [Related]
18. The stimulatory and inhibitory components of cocaine's actions on the 5-HTP-induced 5-HT2A receptor response.
Darmani NA; Reeves SL
Pharmacol Biochem Behav; 1996 Nov; 55(3):387-96. PubMed ID: 8951980
[TBL] [Abstract][Full Text] [Related]
19. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T; Umbers V; Gartside SE
Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
[TBL] [Abstract][Full Text] [Related]
20. Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies.
Sprouse J; Braselton J; Reynolds L; Clarke T; Rollema H
Synapse; 2001 Jul; 41(1):49-57. PubMed ID: 11354013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
